Mestinon and Urosepsis - a phase IV clinical study of FDA data

Summary:

Urosepsis is reported as a side effect among people who take Mestinon (pyridostigmine bromide), especially for people who are female, 30-39 old, also take Pantoprazole, and have Breast cancer.

The phase IV clinical study analyzes which people have Urosepsis when taking Mestinon. It is created by eHealthMe based on reports of 5,613 people who have side effects when taking Mestinon from the FDA, and is updated regularly.

What is Mestinon?

Mestinon has active ingredients of pyridostigmine bromide. It is often used in myasthenia gravis. eHealthMe is studying from 5,948 Mestinon users. Check the latest studies of Mestinon.

What is Urosepsis?

Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream) is found to be associated with 900 drugs and 918 conditions by eHealthMe. Check the latest studies of Urosepsis.

On Jul, 13, 2026

5,613 people reported to have side effects when taking Mestinon.
Among them, 22 people (0.39%) have Urosepsis.

Among these 22 people:

What is the gender of people who have Urosepsis when taking Mestinon? *

female: 100 %
male: 0.0 %

What is the age of people who have Urosepsis when taking Mestinon? *

What are other drugs people take besides Mestinon? *

What are other side effects people have besides Urosepsis? *

Urinary Tract Infection: 13 people, 59.09%
Nausea And Vomiting: 11 people, 50.00%
Rashes (redness): 10 people, 45.45%
Diarrhea: 9 people, 40.91%
Fall: 9 people, 40.91%
Dyspnea Exertional: 9 people, 40.91%
Dizziness: 9 people, 40.91%
Bone Pain: 9 people, 40.91%
Cardiac Failure: 9 people, 40.91%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 9 people, 40.91%

What are the existing conditions these people have? *

Arrhythmias (irregular heartbeat): 9 people, 40.91%
Pain: 9 people, 40.91%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 40.91%
Weakness: 9 people, 40.91%
High Blood Pressure: 9 people, 40.91%
Breast Cancer: 9 people, 40.91%
Vitamin D Decreased: 7 people, 31.82%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 7 people, 31.82%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 27.27%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take Mestinon and have Urosepsis?

- Check whether Urosepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mestinon:

Mestinon (5,948 reports)

Urosepsis treatments and more:

Urosepsis (11,959 reports)

Browse all side effects of Mestinon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urosepsis:

Urosepsis (900 drugs)

Browse all the conditions that are associated with Urosepsis:

Urosepsis (918 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pyridostigmine bromide (the active ingredients of Mestinon) and Mestinon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.